346: Zealand's obesity strategy and Immunovant's curious development plan

The Readout Loud - Ein Podcast von STAT - Donnerstags

Kategorien:

We chat about positive data from Immunovant's autoimmune drug candidate, a patient death linked to Sarepta's gene therapy, and dispatches from our STAT Breakthrough Summit East in New York. We also bring on Zealand Pharma CEO Adam Steensberg to talk about his company’s amylin-targeting obesity treatment, the partnership deal it recently signed with Roche, and his thoughts on the industry's intense focus on weight loss.

Visit the podcast's native language site